Literature DB >> 1555900

The accuracy of the critical velocity test for predicting time to exhaustion during treadmill running.

M L Pepper1, T J Housh, G O Johnson.   

Abstract

The purpose of this investigation was to determine the accuracy of the critical velocity (CV) test for predicting time to exhaustion (time limit = TL) during treadmill running. Ten adult males (mean +/- SD of age = 23 +/- 2 years) volunteered to perform a maximal treadmill test, a CV test, and five exhaustive treadmill runs at 70%, 85%, 100%, 115% and 130% of CV for the determination of actual TL. Related t-tests revealed significant (p less than 0.05) differences between the predicted and actual TL values for velocities equal to 100 and 130% of CV. The correlations between predicted and actual TL values for velocities above CV ranged from r = 0.957 to 0.980 (SEE = 0.28-0.82 minutes). At 100% of CV, the subjects maintained the running pace for an average of 16.43 +/- 6.08 minutes (range = 9.96-31.90 minutes) while, at 85% of CV, 8 of the 10 subjects were able to maintain the running pace for 60 minutes. These findings did not support the validity of the CV test for predicting the actual TL during treadmill running and indicated that, in 20% of the cases, CV overestimated the running velocity that could be maintained for 60 minutes by greater than 15%.

Mesh:

Year:  1992        PMID: 1555900     DOI: 10.1055/s-2007-1021242

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  18 in total

Review 1.  Interval training for performance: a scientific and empirical practice. Special recommendations for middle- and long-distance running. Part II: anaerobic interval training.

Authors:  L V Billat
Journal:  Sports Med       Date:  2001-02       Impact factor: 11.136

Review 2.  The scientific basis for high-intensity interval training: optimising training programmes and maximising performance in highly trained endurance athletes.

Authors:  Paul B Laursen; David G Jenkins
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 3.  Methods to determine aerobic endurance.

Authors:  Laurent Bosquet; Luc Léger; Patrick Legros
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

4.  Physiological responses at five estimates of critical velocity.

Authors:  Anthony J Bull; Terry J Housh; Glen O Johnson; Sharon R Rana
Journal:  Eur J Appl Physiol       Date:  2007-12-19       Impact factor: 3.078

5.  Vmax estimate from three-parameter critical velocity models: validity and impact on 800 m running performance prediction.

Authors:  Laurent Bosquet; Antoine Duchene; François Lecot; Grégory Dupont; Luc Leger
Journal:  Eur J Appl Physiol       Date:  2006-02-09       Impact factor: 3.078

6.  A comparison of critical force and electromyographic fatigue threshold for isometric muscle actions of the forearm flexors.

Authors:  C Russell Hendrix; Terry J Housh; Glen O Johnson; Joseph P Weir; Travis W Beck; Moh H Malek; Michelle Mielke; Richard J Schmidt
Journal:  Eur J Appl Physiol       Date:  2009-01-10       Impact factor: 3.078

Review 7.  The relationship between power output and endurance: a brief review.

Authors:  R H Morton; D J Hodgson
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

8.  Fast-start strategy increases the time spent above 95 %VO2max during severe-intensity intermittent running exercise.

Authors:  Rafael Alves de Aguiar; Tiago Turnes; Rogério Santos de Oliveira Cruz; Fabrizio Caputo
Journal:  Eur J Appl Physiol       Date:  2012-10-02       Impact factor: 3.078

9.  The reliability of the intermittent critical velocity test and assessment of critical rest interval in men and women.

Authors:  David H Fukuda; Abbie E Smith; Kristina L Kendall; Robert P Hetrick; Ryan L Hames; Joel T Cramer; Jeffrey R Stout
Journal:  Eur J Appl Physiol       Date:  2011-07-17       Impact factor: 3.078

Review 10.  Significance of the velocity at VO2max and time to exhaustion at this velocity.

Authors:  L V Billat; J P Koralsztein
Journal:  Sports Med       Date:  1996-08       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.